Human amniotic fluid stem cell preconditioning improves their regenerative potential. - Wikidata - awgldk - TriplyDB

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

http://www.wikidata.org/entity/Q36093158

about

Neuromuscular Regeneration: Perspective on the Application of Mesenchymal Stem Cells and Their Secretion Products Adult stem cells as a tool for kidney regeneration Trophic Factors from Tissue Stem Cells for Renal Regeneration Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.Administration of BMSCs with muscone in rats with gentamicin-induced AKI improves their therapeutic efficacy Activation of regulatory T cells during inflammatory response is not an exclusive property of stem cells The molecular mechanism underlying the proliferating and preconditioning effect of vitamin C on adipose-derived stem cells Potential advantages of acute kidney injury management by mesenchymal stem cells.Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.Capillary-like network formation by human amniotic fluid-derived stem cells within fibrin/poly(ethylene glycol) hydrogels.Megestrol Acetate Increases the Proliferation, Migration, and Adipogenic Differentiation of Adipose-Derived Stem Cells via Glucocorticoid Receptor Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine.Functional Human Podocytes Generated in Organoids from Amniotic Fluid Stem Cells.Amniotic Fluid-Derived Mesenchymal Stem Cells Cut Short the Acuteness of Cisplatin-Induced Nephrotoxicity in Sprague-Dawley Rats Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats CD117(+) amniotic fluid stem cells: state of the art and future perspectives.Mesenchymal stem cells and kidney repair.Preconditioning strategy in stem cell transplantation therapy.Experimental renal progenitor cells: repairing and recreating kidneys?Regeneration and bioengineering of the kidney: current status and future challenges.Stem cells from fetal membranes and amniotic fluid: markers for cell isolation and therapy.Fetal stem cells and skeletal muscle regeneration: a therapeutic approach.Prospect for kidney bioengineering: shortcomings of the status quo.Cell-based therapy for kidney disease.Stem cell therapy for kidney disease.Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.Glial cell line-derived neurotrophic factor induced the differentiation of amniotic fluid-derived stem cells into vascular endothelial-like cells in vitro.Neuroprotective effects of GDNF-expressing human amniotic fluid cells.Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.Amniotic fluid cells: current progress and emerging challenges in renal regeneration.Mesenchymal Stem Cells in Kidney Repair.The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System.Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?Human stem cells alter the invasive properties of somatic cells via paracrine activation of mTORC1 Amniotic fluid and amniotic membrane stem cells: marker discovery.3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney

P2860

Q26765840-7689D20A-1E55-467A-A05C-347ADFAE4B3A Q26770750-68F19390-367D-40E7-A5A9-4D7241AA7315 Q26829361-F7226AAE-BEAC-483A-9BFC-C4E1EF2BC0A8 Q26865171-4CB290B9-93B0-456A-BEC8-BBE449BBDF38 Q27026350-5DA9E664-86CE-4F93-BFF7-B74D0DDCBC53 Q27329535-86D64793-053B-454C-9600-7F50F574CCC2 Q28538772-72325256-A75B-469C-8562-BDDEB503A4EC Q28730432-EF4878A7-37E2-485E-BC0A-5DCF2978A195 Q33713771-0075181E-EFBA-4D3F-8A46-BC73A7618FB6 Q34259151-8C2913DD-513C-47AC-B0EB-11126E7FDDA8 Q34751229-E2C48BCA-9391-4A7D-884E-08CE3E741DE8 Q35153295-039F9AB8-DBC2-4C47-8792-160920664EC4 Q35386835-8B33CA0B-A6AC-4E01-A252-653C72456269 Q35777541-36D6EC0F-DB48-4900-BE8D-272705046BD4 Q36234999-8608F6DD-65C6-4976-93FA-B62A4ACE537C Q36326880-9D22A8AE-2760-4476-BAA6-B85C5C7A7ADB Q36849227-EF883376-6149-4411-8C85-BB86C401A0AC Q37126551-391CA771-0D1E-4FBF-B0A9-C6F515E2DD39 Q37377889-78AC7B7A-A946-4EDD-ABA0-EA02D91D8A55 Q38049499-19A6A68D-B6D7-4DDC-B29C-57625E598841 Q38069136-00A84625-4E7F-4EBB-BAAD-6E381F89408C Q38126494-A56E5F4A-F231-4378-A838-270E06AC2A08 Q38162111-79E50076-DD6A-4D83-8E80-4CB32C22EECB Q38174492-0B027491-F4D4-4DDC-AB70-0C1E6FF5D642 Q38189737-68B64BC3-8F9B-4459-B004-5CCB332A78FA Q38249175-01A80C98-7FEE-4929-B197-83F6510C7360 Q38339791-3A0AFD32-5C3D-43CA-9AF1-522972887F7B Q38528934-A2A7443A-9CF9-479D-AD11-A9B5AC5E5DF8 Q38544667-9DF6BB08-ADF0-4116-A534-51EE92908A38 Q38658621-A69010E9-E0BD-4EFF-924C-184E405D7B1C Q38808348-A9A6D005-FFF6-407F-9E99-5F0976A9DFF4 Q39035207-BFC745B8-872D-4E31-A6CF-0E91489A2D7F Q39078340-34300A75-1A59-43AA-BBEF-261D1D553FA1 Q39377520-6C61C678-84DE-4BA6-869A-314CBD74AB5B Q39728180-9051E66A-AA5E-407A-95A9-4ECE047BA0EB Q40295198-058A4139-FD5D-4FAD-95F5-B9CB61FBAA8B Q41212597-5F5E997E-E29B-4851-9378-7BCA18FA7E9E Q41701136-C15E6FB5-033B-4E9F-9C2A-D0A37E096B61 Q42196647-B799AB44-D705-412D-BCB2-C01D35FA6F20 Q42464603-33475499-5137-418A-BE01-576CEB996104

P2860

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

http://www.wikidata.org/entity/Q36093158

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

@ast

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

@en

type

label

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

@ast

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

@en

prefLabel

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

@ast

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

@en

P1433

Q36093158-5214903A-59A5-45CB-96B4-D1674A0E11BE

P1476

Q36093158-F6291D34-AD9A-4CCC-ABEA-64A3497E2075

P2093

Q36093158-1883F2A6-E949-4228-9711-3F2BBFC55604

Q36093158-2896EB09-59C4-4A15-98BB-70DB97137A55

Q36093158-2ECE2503-48E3-45D2-9990-39289CE3330B

Q36093158-7FFF4613-5055-478A-8A36-843116149019

Q36093158-82170051-8AEB-4E89-9297-7E2910BB7C57

Q36093158-B419E984-C154-45C6-9FA3-19B65A4BAA9B

Q36093158-E8C93122-2D6A-4FDA-8503-9CD2B8C985DC

Q36093158-F2242631-CC2B-478D-86C5-D40698A0CEA5

P2860

Q36093158-00B67288-1DD1-4785-ADEE-1AE4692CF5AA

Q36093158-02FDE5AE-9AAD-4D4E-A2B2-278042E48096

Q36093158-046677E7-DECA-4BD7-BAD4-EEC790FC5A72

Q36093158-10BB0E2F-14FC-4F62-90FC-A655C736DD52

Q36093158-21115DAD-1433-4550-9FCD-34BF34C5C674

Q36093158-2A58E9B4-F786-4450-B74C-69A235CB12AD

Q36093158-36553C7A-7E8F-4571-85D4-D18D936D536F

Q36093158-3C00083D-57ED-426F-905B-81144327F47D

Q36093158-460332DA-B6E8-496F-A76E-F82CB5A6FFBD

Q36093158-49473167-1CEB-4E33-98CD-AF4B9FE6CBD9

P304

Q36093158-CC7EC8C9-C674-4415-AECB-95AFBD5AC24B

P31

Q36093158-94D3A47B-F1E7-418A-85B8-C40CB701AC05

P356

Q36093158-A17BAB9E-49FA-4B81-9545-6D6C0EA5DCB4

P433

Q36093158-DD2A97E5-DA87-4DE4-ABB1-049CA5C83E7A

P478

Q36093158-AE4359A5-0A6E-44CC-BD3F-A9D7D81E97B0

P50

Q36093158-036FDCC8-B9ED-4D08-8325-7B6393CC5138

Q36093158-05E79F65-63CF-42BA-8966-23D436A12FFA

Q36093158-170264F3-35DB-44DC-BDCA-E5715D7AB10A

Q36093158-59A4B639-CB90-44ED-A644-ADD96C8E799A

Q36093158-6E09EB1E-245F-4BB2-A4B9-28BA6CD931E5

Q36093158-71803445-58FA-4ECF-AD6B-70F40EBC104A

Q36093158-B8E73BD2-F3F5-4841-BD15-B189AB7D388A

P577

Q36093158-533217AB-E59D-4121-A579-6E0433B5C65D

P5875

Q36093158-92789438-C519-4004-94D7-B751F26A3CBF

P698

Q36093158-B174FFB1-D1B6-462C-AFC8-D048097043DD

P932

Q36093158-E0792BDF-F99B-4EA8-8ED9-19A4C30D3F54

P356

P1433

Stem Cells and Development

P1476

Human amniotic fluid stem cell preconditioning improves their regenerative potential.

@en

P2093

Barbara Imberti

http://www.w3.org/2001/XMLSchema#string

Cinzia Rota

http://www.w3.org/2001/XMLSchema#string

Elena Gagliardini

http://www.w3.org/2001/XMLSchema#string

Elisa Squarcina

http://www.w3.org/2001/XMLSchema#string

Marina Morigi

http://www.w3.org/2001/XMLSchema#string

Martina Piccoli

http://www.w3.org/2001/XMLSchema#string

Mauro Abbate

http://www.w3.org/2001/XMLSchema#string

Valentina Benedetti

http://www.w3.org/2001/XMLSchema#string

P2860

Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis

IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins

Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Cellular survival: a play in three Akts

Vascular endothelial growth factor (VEGF) and its receptors

Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.

Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo

Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney.

P304

1911-1923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/SCD.2011.0333

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

Christodoulos Xinaris

Aline S C Fabricio

Michela Pozzobon

P577

2011-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51782757

http://www.w3.org/2001/XMLSchema#string

P698

22066606

http://www.w3.org/2001/XMLSchema#string

P932

3396139

http://www.w3.org/2001/XMLSchema#string